These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24115340)

  • 21. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antidepressants and association with elective termination of pregnancy: population based case-control study.
    Kieler H; Malm H; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BJOG; 2015 Nov; 122(12):1618-24. PubMed ID: 25395328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunct mirtazapine for negative symptoms of schizophrenia.
    Phan SV; Kreys TJ
    Pharmacotherapy; 2011 Oct; 31(10):1017-30. PubMed ID: 21950644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of antidepressive agents and the mortality of end-stage renal disease.
    Tsai CJ; Loh el-W; Lin CH; Yu TM; Chan CH; Lan TH
    Nephrology (Carlton); 2012 May; 17(4):390-7. PubMed ID: 22260522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N; Kargili A; Akcay A; Kaya A
    Am J Kidney Dis; 2006 Oct; 48(4):e61-2. PubMed ID: 16997047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescribing a sedative antidepressant for patients at work or on sick leave under conditions of routine care.
    Linden M; Westram A
    Pharmacopsychiatry; 2010 Jan; 43(1):1-6. PubMed ID: 20013553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open trial of mirtazapine in patients with fibromyalgia.
    Samborski W; Lezanska-Szpera M; Rybakowski JK
    Pharmacopsychiatry; 2004 Jul; 37(4):168-70. PubMed ID: 15467973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Parkinson disease after depression: a nationwide population-based study.
    Shen CC; Tsai SJ; Perng CL; Kuo BI; Yang AC
    Neurology; 2013 Oct; 81(17):1538-44. PubMed ID: 24089392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mirtazapine associated with profound hyponatremia: two case reports.
    Cheah CY; Ladhams B; Fegan PG
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):91-5. PubMed ID: 18675767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tourette syndrome and risk of depression: a population-based cohort study in Taiwan.
    Chou IC; Lin HC; Lin CC; Sung FC; Kao CH
    J Dev Behav Pediatr; 2013 Apr; 34(3):181-5. PubMed ID: 23572168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reboxetine addition in patients with mirtazapine-resistant depression: a case series.
    López-Muñoz F; Rubio G; Alamo C; García-García P; Pardo A
    Clin Neuropharmacol; 2006; 29(4):192-6. PubMed ID: 16855420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer and antidepressants.
    Wu CS; Lu ML; Liao YT; Lee CT; Chen VC
    Psychooncology; 2015 May; 24(5):579-84. PubMed ID: 25335924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.